342 related articles for article (PubMed ID: 26049759)
1. The role of aberrant proteolysis in lymphomagenesis.
Sahasrabuddhe AA; Elenitoba-Johnson KS
Curr Opin Hematol; 2015 Jul; 22(4):369-78. PubMed ID: 26049759
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Epithelial-Mesenchymal Transition by E3 Ubiquitin Ligases and Deubiquitinase in Cancer.
Inoue Y; Itoh Y; Sato K; Kawasaki F; Sumita C; Tanaka T; Morishita D; Hayashi H
Curr Cancer Drug Targets; 2016; 16(2):110-8. PubMed ID: 26560121
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitination: Friend and foe in cancer.
Mansour MA
Int J Biochem Cell Biol; 2018 Aug; 101():80-93. PubMed ID: 29864543
[TBL] [Abstract][Full Text] [Related]
4. Role of the ubiquitin proteasome system in hematologic malignancies.
Sahasrabuddhe AA; Elenitoba-Johnson KS
Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin recognition by the proteasome.
Saeki Y
J Biochem; 2017 Feb; 161(2):113-124. PubMed ID: 28069863
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of ubiquitin ligases in cancer.
Qi J; Ronai ZA
Drug Resist Updat; 2015 Nov; 23():1-11. PubMed ID: 26690337
[TBL] [Abstract][Full Text] [Related]
7. The demographics of the ubiquitin system.
Clague MJ; Heride C; Urbé S
Trends Cell Biol; 2015 Jul; 25(7):417-26. PubMed ID: 25906909
[TBL] [Abstract][Full Text] [Related]
8. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
Liu L; Wong CC; Gong B; Yu J
Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
[TBL] [Abstract][Full Text] [Related]
9. Systematic approaches to identify E3 ligase substrates.
Iconomou M; Saunders DN
Biochem J; 2016 Nov; 473(22):4083-4101. PubMed ID: 27834739
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Lys-ϵ-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1.
Thompson JW; Nagel J; Hoving S; Gerrits B; Bauer A; Thomas JR; Kirschner MW; Schirle M; Luchansky SJ
J Biol Chem; 2014 Oct; 289(42):28942-55. PubMed ID: 25147182
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin proteasome system in immune regulation and therapeutics.
Bhat SA; Vasi Z; Adhikari R; Gudur A; Ali A; Jiang L; Ferguson R; Liang D; Kuchay S
Curr Opin Pharmacol; 2022 Dec; 67():102310. PubMed ID: 36288660
[TBL] [Abstract][Full Text] [Related]
12. HECT-Type E3 Ubiquitin Ligases in Cancer.
Bernassola F; Chillemi G; Melino G
Trends Biochem Sci; 2019 Dec; 44(12):1057-1075. PubMed ID: 31610939
[TBL] [Abstract][Full Text] [Related]
13. The deubiquitinase Leon/USP5 regulates ubiquitin homeostasis during Drosophila development.
Wang CH; Chen GC; Chien CT
Biochem Biophys Res Commun; 2014 Sep; 452(3):369-75. PubMed ID: 25152394
[TBL] [Abstract][Full Text] [Related]
14. Perilous journey: a tour of the ubiquitin-proteasome system.
Kleiger G; Mayor T
Trends Cell Biol; 2014 Jun; 24(6):352-9. PubMed ID: 24457024
[TBL] [Abstract][Full Text] [Related]
15. Role of ubiquitin ligases in neural stem and progenitor cells.
Naujokat C
Arch Immunol Ther Exp (Warsz); 2009; 57(3):177-88. PubMed ID: 19479207
[TBL] [Abstract][Full Text] [Related]
16. The role of the ubiquitin proteasome system in lymphoma.
Suh KS; Tanaka T; Sarojini S; Nightingale G; Gharbaran R; Pecora A; Goy A
Crit Rev Oncol Hematol; 2013 Sep; 87(3):306-22. PubMed ID: 23541070
[TBL] [Abstract][Full Text] [Related]
17. [Application of proteomics in deubiquitinases research].
Li Y; Gao Y; Xu Z; Lan Q; Xu P
Sheng Wu Gong Cheng Xue Bao; 2014 Sep; 30(9):1341-50. PubMed ID: 25720149
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitinating enzyme inhibitors and their potential in cancer therapy.
Crosas B
Curr Cancer Drug Targets; 2014; 14(6):506-16. PubMed ID: 25088039
[TBL] [Abstract][Full Text] [Related]
19. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.
von Mikecz A; Chen M; Rockel T; Scharf A
Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-specific protease 14 is a new therapeutic target for the treatment of diseases.
Wang D; Ma H; Zhao Y; Zhao J
J Cell Physiol; 2021 May; 236(5):3396-3405. PubMed ID: 33135160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
